# Atox Bio

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/atox-bio

- Industry: Pharmaceuticals
- Headquarters: Durham, US
- Website: www.atoxbio.com
- Total disclosed funding: $53M
- Latest round: Series F (Dec 4, 2017)
- Investors on record: 8

## About

Founded in 2003 and based in Ness Ziona, Israel, Atox Bio Inc. is a biotechnology company that develops immunomodulators for the treatment of life-threatening diseases caused by infections.

## Funding rounds

- Series F, Dec 4, 2017, $30M — Adams Street Partners, OrbiMed Advisors, SR One, Becker Group, Lundbeckfond Ventures, Asahi Kasei Corporation, Integra Holdings, Arix Bioscience
- Series E, Jul 24, 2014, $23M — OrbiMed Advisors, SR One, Lundbeckfond Ventures

## Investors

- OrbiMed Advisors (https://capitalatlas.ai/funds/orbimed-advisors) — Series E, Series F
- SR One (https://capitalatlas.ai/funds/sr-one) — Series E, Series F
- Lundbeckfond Ventures (https://capitalatlas.ai/funds/lundbeckfond-ventures) — Series E, Series F
- Adams Street Partners (https://capitalatlas.ai/funds/adams-street-partners) — Series F
- Becker Group — Series F
- Asahi Kasei Corporation — Series F
- Integra Holdings (https://capitalatlas.ai/funds/integra-holdings) — Series F
- Arix Bioscience (https://capitalatlas.ai/funds/arix-bioscience) — Series F